testing capabilities available to veterinarians. The IDEXX
VetLab Suite is a highly integrated set of veterinary analyzers that
provides fast and flexible results on a patient's blood and urine within
minutes of the pet visit. Diagnostic capabilities of the Suite include
clinical chemistry, electrolytes, hematology with five-part differential
and reticulocytes, endocrinology, blood gases, coagulation, urinalysis and
infectious diseases. The IDEXX VetLab(R) Station, which serves as an
information system for the in-house laboratory, uses the power of
SmartLink(TM) technology to integrate results from all the
analyzers-including the new Catalyst Dx and SNAPshot Dx-and IDEXX SNAP(R)
point-of-care tests into a single comprehensive and easy-to-use patient
report and stores this information in its database for easy future
reference and historical results-trending capability.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in companion animal health,
serving practicing veterinarians around the world with innovative,
technology-based offerings, including a broad range of diagnostic products
and services, practice management systems and pharmaceuticals. IDEXX
products enhance the ability of veterinarians to provide advanced medical
care and to build more economically successful practices. IDEXX is also a
worldwide leader in providing diagnostic tests and information for the
production animal industry and tests for the quality and safety of water
and milk. Headquartered in Maine, IDEXX Laboratories employs more than
4,500 people and offers products to customers in over 100 countries.
Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155
(Logo: http://www.newscom.com/cgi-bin/prnh/20030305/IDEXXLOGO )
'/>"/>SOURCE IDEXX Laboratories, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Stonegate Report About Unigene Laboratories Inc.2.
Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego3.
White Paper Details Environmental Health & Safety Compliance Strategies for Laboratories4.
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement5.
Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation6.
Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems7.
Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement8.
Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories9.
Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer10.
Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control11.
Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB